Lehrstuhl für Geburtshilfe und Frauenheilkunde

Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer (2021) Lüftner D, Hartkopf AD, Lux MP, Overkamp F, Tesch H, Titzmann A, Pöschke P, et al. Journal article, Review article Endometriose – gynäkologische Diagnostik und Therapie: Was sollten Schmerzmediziner*innen wissen? (2021) Burghaus S, Beckmann M Journal article, Review article Prenatal alcohol exposure and the facial phenotype in adolescents: A study based on meconium ethyl glucuronide (2021) Maschke J, Roetner J, Goecke T, Fasching P, Beckmann M, Kratz O, Moll G, et al. Journal article Active Participation, Mind–Body Stabilization, and Coping Strategies with Integrative Medicine in Breast Cancer Patients (2021) Theuser AK, Antoniadis S, Langemann H, Wasner S, Grasruck K, Dietzel-Drentwett S, Fasching P, et al. Journal article Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers (2021) Glubb DM, Thompson DJ, Aben KKH, Alsulimani A, Amant F, Annibali D, Attia J, et al. Journal article Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study (2021) Prieske K, Woelber L, Muallem MZ, Eulenburg C, Jueckstock JK, Hilpert F, de Gregorio N, et al. Journal article Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy☆ (2021) Denkert C, Untch M, Benz S, Schneeweiss A, Weber KE, Schmatloch S, Jackisch C, et al. Journal article Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix (2021) Stübs F, Gaß P, Dietl A, Schulmeyer C, Adler W, Geppert CI, Hartmann A, et al. Journal article Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses (2021) Kang EY, Cheasley D, LePage C, Wakefield MJ, da Cunha Torres M, Rowley S, Salazar C, et al. Journal article Corrigendum to “Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany” (The Breast (2020) 54 (88–95), (S0960977620301648), (10.1016/j.breast.2020.08.011)) (2021) Schneeweiss A, Ettl J, Lüftner D, Beckmann M, Belleville E, Fasching P, Fehm TN, et al. Journal article, Erratum